• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased μ-opioid receptor expression in metastatic lung cancer.转移性肺癌中 μ-阿片受体表达增加。
Br J Anaesth. 2014 Jul;113 Suppl 1(Suppl 1):i103-8. doi: 10.1093/bja/aeu165. Epub 2014 Jun 11.
2
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.μ 阿片受体在肺癌进展中的新作用:一项实验室研究。
Anesth Analg. 2011 Mar;112(3):558-67. doi: 10.1213/ANE.0b013e31820568af. Epub 2010 Dec 14.
3
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.μ 阿片受体在人非小细胞肺癌中的过表达促进 Akt 和 mTOR 的激活、肿瘤生长和转移。
Anesthesiology. 2012 Apr;116(4):857-67. doi: 10.1097/ALN.0b013e31824babe2.
4
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.μ阿片受体促进阿片类药物和生长因子诱导的人肺癌细胞增殖、迁移及上皮-间质转化(EMT)。
PLoS One. 2014 Mar 24;9(3):e91577. doi: 10.1371/journal.pone.0091577. eCollection 2014.
5
Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.一种靶向μ和δ阿片受体用于肺癌药物递送的配体的合成与评价
Bioorg Med Chem Lett. 2017 May 1;27(9):2074-2078. doi: 10.1016/j.bmcl.2016.06.067. Epub 2016 Jun 28.
6
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.吗啡诱导非小细胞肺癌表皮生长因子通路激活。
Anesth Analg. 2011 Dec;113(6):1353-64. doi: 10.1213/ANE.0b013e318232b35a. Epub 2011 Oct 14.
7
Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.μ-阿片受体表达与食管鳞状细胞癌淋巴结转移的相关性
Dis Esophagus. 2015 Feb-Mar;28(2):196-203. doi: 10.1111/dote.12165. Epub 2014 Jan 15.
8
The effect of anesthetic technique on µ-opioid receptor expression and immune cell infiltration in breast cancer.麻醉技术对乳腺癌中 µ 阿片受体表达和免疫细胞浸润的影响。
J Anesth. 2018 Dec;32(6):792-796. doi: 10.1007/s00540-018-2554-0. Epub 2018 Sep 18.
9
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.晚期前列腺癌患者的阿片类药物需求、阿片受体表达与临床结局。
Cancer. 2013 Dec 1;119(23):4103-10. doi: 10.1002/cncr.28345. Epub 2013 Sep 16.
10
The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma.μ-阿片受体(MOR)促进肝癌的肿瘤起始。
Cancer Lett. 2019 Jul 1;453:1-9. doi: 10.1016/j.canlet.2019.03.038. Epub 2019 Mar 27.

引用本文的文献

1
Evolution of pain management in lung cancer surgery: from opioid-based to personalized analgesia.肺癌手术中疼痛管理的演变:从基于阿片类药物到个性化镇痛
Anesth Pain Med (Seoul). 2025 Apr;20(2):109-120. doi: 10.17085/apm.25240. Epub 2025 Apr 30.
2
Opioid System and Epithelial-Mesenchymal Transition.阿片类系统与上皮-间质转化
Pharmaceuticals (Basel). 2025 Jan 17;18(1):120. doi: 10.3390/ph18010120.
3
Anesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review.麻醉方法及其对癌症复发和转移的影响:综述
Cancers (Basel). 2024 Dec 22;16(24):4269. doi: 10.3390/cancers16244269.
4
Anesthesia and cancer.麻醉与癌症。
Rev Assoc Med Bras (1992). 2024 Jun 7;70(suppl 1):e2024S102. doi: 10.1590/1806-9282.2024S102. eCollection 2024.
5
Anesthesia and cancer recurrence: a narrative review.麻醉与癌症复发:一篇综述
Anesth Pain Med (Seoul). 2024 Apr;19(2):94-108. doi: 10.17085/apm.24041. Epub 2024 Apr 30.
6
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy.低剂量纳曲酮作为联合抗癌治疗的辅助药物
Cancers (Basel). 2024 Mar 21;16(6):1240. doi: 10.3390/cancers16061240.
7
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.阿片类药物使用对接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者的治疗持续时间和总生存期的影响。
Curr Oncol. 2024 Jan 3;31(1):260-273. doi: 10.3390/curroncol31010017.
8
Comparison of the effects of sufentanil-dominant anaesthesia/analgesia and epidural anaesthesia/analgesia on postoperative immunological alterations, stress responses and prognosis in open hepatectomy: a randomized trial.舒芬太尼主导的麻醉/镇痛与硬膜外麻醉/镇痛对开放性肝切除术后免疫改变、应激反应及预后影响的比较:一项随机试验
J Gastrointest Oncol. 2023 Dec 31;14(6):2521-2535. doi: 10.21037/jgo-23-711. Epub 2023 Nov 15.
9
Opioids and cancer survival: are we looking in the wrong place?阿片类药物与癌症生存率:我们找错方向了吗?
BJA Open. 2022 May 11;2:100010. doi: 10.1016/j.bjao.2022.100010. eCollection 2022 Jun.
10
The Role of Anesthetic Drugs and Statins in Prostate Cancer Recurrence: Starting at the Actual Knowledge and Walking through a New Paradigm.麻醉药物和他汀类药物在前列腺癌复发中的作用:从实际知识出发,迈向新范式
Cancers (Basel). 2023 Jun 5;15(11):3059. doi: 10.3390/cancers15113059.

本文引用的文献

1
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.μ阿片受体促进阿片类药物和生长因子诱导的人肺癌细胞增殖、迁移及上皮-间质转化(EMT)。
PLoS One. 2014 Mar 24;9(3):e91577. doi: 10.1371/journal.pone.0091577. eCollection 2014.
2
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.晚期前列腺癌患者的阿片类药物需求、阿片受体表达与临床结局。
Cancer. 2013 Dec 1;119(23):4103-10. doi: 10.1002/cncr.28345. Epub 2013 Sep 16.
3
Hemiarthroplasty in high risk elderly patient under epidural anesthesia with 0.75% ropivacaine-fentanyl versus 0.5% bupivacaine-fentanyl: Clinical trial.在硬膜外麻醉下,0.75%罗哌卡因-芬太尼与0.5%布比卡因-芬太尼用于高危老年患者半髋关节置换术的临床试验
Saudi J Anaesth. 2013 Apr;7(2):142-5. doi: 10.4103/1658-354X.114058.
4
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.桩蛋白突变影响焦点黏附,并导致线粒体动力学改变:与肺癌的相关性。
Cancer Biol Ther. 2013 Jul;14(7):679-91. doi: 10.4161/cbt.25091. Epub 2013 May 31.
5
Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population.A118G 多态性与中国人群食管鳞癌风险相关。
Int J Clin Oncol. 2013 Aug;18(4):666-9. doi: 10.1007/s10147-012-0441-5. Epub 2012 Jul 3.
6
μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer.μ-阿片受体基因 A118G 多态性预测乳腺癌患者的生存。
Anesthesiology. 2012 Apr;116(4):896-902. doi: 10.1097/ALN.0b013e31824b96a1.
7
The μ-opioid receptor in cancer progression: is there a direct effect?μ-阿片受体在癌症进展中的作用:是否存在直接影响?
Anesthesiology. 2012 Apr;116(4):940-5. doi: 10.1097/ALN.0b013e31824b9512.
8
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.μ 阿片受体在人非小细胞肺癌中的过表达促进 Akt 和 mTOR 的激活、肿瘤生长和转移。
Anesthesiology. 2012 Apr;116(4):857-67. doi: 10.1097/ALN.0b013e31824babe2.
9
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.吗啡诱导非小细胞肺癌表皮生长因子通路激活。
Anesth Analg. 2011 Dec;113(6):1353-64. doi: 10.1213/ANE.0b013e318232b35a. Epub 2011 Oct 14.
10
Cancer recurrence after surgery: direct and indirect effects of anesthetic agents.手术后癌症复发:麻醉剂的直接和间接影响。
Int J Cancer. 2012 Mar 15;130(6):1237-50. doi: 10.1002/ijc.26448. Epub 2011 Nov 9.

转移性肺癌中 μ-阿片受体表达增加。

Increased μ-opioid receptor expression in metastatic lung cancer.

机构信息

Department of Medicine, Section of Pulmonary and Critical Care, Department of Anesthesia and Critical Care and

Department of Medicine, Section of Pulmonary and Critical Care.

出版信息

Br J Anaesth. 2014 Jul;113 Suppl 1(Suppl 1):i103-8. doi: 10.1093/bja/aeu165. Epub 2014 Jun 11.

DOI:10.1093/bja/aeu165
PMID:24920011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4111280/
Abstract

BACKGROUND

We and others have previously demonstrated that the μ-opioid receptor (MOR) is overexpressed in several human malignancies. There is a seven-fold increase in MOR in cell lines of human lung cancer. In animal models, overexpression of MOR promotes tumour growth and metastasis. We, therefore, examined whether MOR expression is increased in metastatic lung cancer.

METHODS

In this study, we examined the association between MOR expression and metastasis in archived biopsy samples from patients with lung cancer. Paraffin-embedded patient material was stained using MOR antibody and scored qualitatively by two independent pathologists using a four-point scale.

RESULTS

In human lung cancer and normal adjacent lung samples obtained from 34 lung cancer patients, MOR expression was increased significantly in cancer samples from patients with lung cancer compared with adjacent control tissue (P=0.0242). When the samples from patients with metastatic lung cancer were separated from the cohort of the total number of patients with lung cancer, we observed an approximately two-fold increase in MOR expression (P=0.0013).

CONCLUSIONS

The association between the expression of MOR and the progression of the tumour is consistent with the hypothesis of a direct effect of MOR on cancer progression.

摘要

背景

我们和其他人之前已经证明 μ-阿片受体(MOR)在几种人类恶性肿瘤中过度表达。在人类肺癌细胞系中,MOR 的表达增加了七倍。在动物模型中,MOR 的过度表达促进肿瘤生长和转移。因此,我们研究了转移性肺癌中 MOR 表达是否增加。

方法

在这项研究中,我们检查了 MOR 表达与存档的肺癌患者活检样本中转移之间的关联。使用 MOR 抗体对石蜡包埋的患者标本进行染色,并由两位独立的病理学家使用四点量表进行定性评分。

结果

在从 34 名肺癌患者获得的人肺癌和正常相邻肺样本中,与相邻对照组织相比,来自肺癌患者的癌症样本中 MOR 表达显著增加(P=0.0242)。当将来自转移性肺癌患者的样本与肺癌患者总数的队列分开时,我们观察到 MOR 表达增加了大约两倍(P=0.0013)。

结论

MOR 表达与肿瘤进展之间的关联与 MOR 对癌症进展的直接影响的假设一致。